Author: Sara Burke

26 Aug

Posted at 06:30h in Press Releases

Woburn, MA – August 26, 2021 – Neurogastrx, Inc., a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal (GI) disorders, announced today the successful completion of a $60 million Series B crossover round led by Vivo Capital. Other new investors participating in the...

05 Jul

Posted at 14:48h in Career Opportunities

Donec adipiscing tristique risus nec feugiat. Dolor sit amet consectetur adipiscing elit pellentesque habitant morbi tristique. Ornare quam viverra orci sagittis eu volutpat odio. Cras ornare arcu dui vivamus arcu felis bibendum ut tristique. Aliquam malesuada bibendum arcu vitae elementum curabitur. Id consectetur purus ut...

04 Jul

Posted at 14:51h in Career Opportunities

Eget magna fermentum iaculis eu non. Volutpat diam ut venenatis tellus in metus vulputate eu scelerisque. Morbi tristique senectus et netus et malesuada fames ac turpis. Magna sit amet purus gravida quis blandit turpis cursus. Faucibus vitae aliquet nec ullamcorper sit amet risus nullam. Viverra...

08 Jun

Posted at 09:00h in Press Releases

Woburn, MA – June 8, 2021 – Neurogastrx, Inc., a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal (GI) disorders, announced today that it has entered into an exclusive license agreement with Daewoong Pharmaceutical Co., Ltd., of Seoul, South Korea, for the development...